A Study Of Quai.MD AI-based Platform For Chest Pain Related Pathways
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 26-003116
About this study
The purpose of this study is to demonstrate the value of the Quai platform in implementing pathways, we propose the following primary objectives for this pilot:
Demonstrate that implementation of the Quai.MD platform improves chest pain/shortness of breath (ACS/PE) clinical pathways adherence in the emergency department
Demonstrate the usability of the Quai.MD application and its smooth integration into the providers’ workflow in Epic
Demonstrate that implementing pathways using the Quai platform brings direct economic value to the ED
To gain a wide-spectrum view on implementation at the providers’ workspace to learn about the interplay of pathway use and clinical workflow.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
Exclusion Criteria:
Providers caring for patients who present to the Emergency Department at St. Marys with patients showing an ST segment elevation myocardial infarction (STEMI) or in cardiac arrest before or during their ED course.
Providers unable or unwilling to consent to participate in the Quai MD pathway project.
Patients who have declined research authorization.
Patients under the age of 18 at the time of ED presentation.
Note: Other protocol defined Inclusion/Exclusion Criteria may apply.
Eligibility last updated 03/18/2026. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Laura Walker, M.D., M.B.A. |
Contact us for the latest status |
|
More information
Publications
Publications are currently not available